Zydus Life shares snap 3 day slide on Zyrifa launch, Formycon partnership; stock up 2%
Published on: Dec. 10, 2025, 11:25 a.m. | Source: Business Today
The Ahmedabad-headquartered firm announced the launch of 'Zyrifa', a biosimilar of Denosumab, aimed at protecting bone health in cancer patients. Priced at an MRP of Rs 12,495.
